XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 8,086 $ 9,371
General and administrative 5,299 5,122
Restructuring 1,207 0
Total operating expenses 14,592 14,493
Loss from operations (14,592) (14,493)
Interest income 547 49
Other income (expense), net (252) 6,497
Net loss (14,297) (7,947)
Unrealized gain (loss) on marketable securities, net of tax 191 (310)
Comprehensive loss $ (14,106) $ (8,257)
Net loss per share attributable to common stockholders, basic $ (0.48) $ (0.23)
Net loss per share attributable to common stockholders, diluted $ (0.48) $ (0.23)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic 29,971 34,863,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted 29,971 34,863,000